Biotech company operating a 503A drug compounding facility for eye products
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2022 | FTI GOVERNMENT AFFAIRS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
— | |
| 2022 | FTI GOVERNMENT AFFAIRS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2021 | FTI GOVERNMENT AFFAIRS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2021 | FTI GOVERNMENT AFFAIRS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2021 | FTI GOVERNMENT AFFAIRS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2021 | FTI GOVERNMENT AFFAIRS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2020 | FTI GOVERNMENT AFFAIRS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2020 | FTI GOVERNMENT AFFAIRS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2020 | FTI GOVERNMENT AFFAIRS |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FTI GOVERNMENT AFFAIRS | 9 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 9 |